- Home
- ADMA vs CSAN Comparison
ADMA vs CSAN Comparison
Compare ADMA & CSAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADMA
- CSAN
- Stock Information
- Founded
- ADMA 2004
- CSAN 1936
- Country
- ADMA United States
- CSAN Brazil
- Employees
- ADMA N/A
- CSAN N/A
- Industry
- ADMA Biotechnology: Biological Products (No Diagnostic Substances)
- CSAN Retail-Auto Dealers and Gas Stations
- Sector
- ADMA Health Care
- CSAN Consumer Discretionary
- Exchange
- ADMA Nasdaq
- CSAN Nasdaq
- Market Cap
- ADMA 4.1B
- CSAN 2.5B
- IPO Year
- ADMA N/A
- CSAN N/A
- Fundamental
- Price
- ADMA $16.32
- CSAN $5.49
- Analyst Decision
- ADMA Strong Buy
- CSAN Strong Buy
- Analyst Count
- ADMA 4
- CSAN 1
- Target Price
- ADMA $21.25
- CSAN $19.00
- AVG Volume (30 Days)
- ADMA 2.3M
- CSAN 1.2M
- Earning Date
- ADMA 02-26-2025
- CSAN 02-26-2025
- Dividend Yield
- ADMA N/A
- CSAN 6.33%
- EPS Growth
- ADMA N/A
- CSAN N/A
- EPS
- ADMA 0.28
- CSAN 0.22
- Revenue
- ADMA $382,809,000.00
- CSAN $7,655,547,290.00
- Revenue This Year
- ADMA $67.03
- CSAN $318.70
- Revenue Next Year
- ADMA $14.58
- CSAN $0.13
- P/E Ratio
- ADMA $58.22
- CSAN $6.11
- Revenue Growth
- ADMA 63.39
- CSAN 3.43
- 52 Week Low
- ADMA $4.82
- CSAN $5.09
- 52 Week High
- ADMA $23.64
- CSAN $15.56
- Technical
- Relative Strength Index (RSI)
- ADMA 36.43
- CSAN 40.28
- Support Level
- ADMA $17.82
- CSAN $5.27
- Resistance Level
- ADMA $18.88
- CSAN $5.61
- Average True Range (ATR)
- ADMA 0.84
- CSAN 0.18
- MACD
- ADMA -0.08
- CSAN 0.08
- Stochastic Oscillator
- ADMA 12.01
- CSAN 57.14
About ADMA ADMA Biologics Inc
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.
About CSAN Cosan S.A. ADS
Cosan SA engages in several services throughout the energy and logistics sectors. Its reportable segments are Raizen, Compass, Moove, Rumo, and Radar. It generates the majority of its revenue from Raizen which operates in the production, commercialization, origination, and trading of ethanol, bioenergy, resale, and trading of electricity, renewable sources, marketing, origination, and trading of sugar and fuels, and lubricant.